New publication from HPR

aldric-hama
Dec 27, 2024
1 min read

"Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age‐Related Macular Degeneration"

OCT images of NHP macula before and after intravitreal administration of sodium iodate.

Recent Posts

Notice Regarding Organizational Restructuring of Group Companies

We hereby announce that our subsidiaries, CMIC Pharma Science Co., Ltd. (Head Office: Hokuto City, Yamanashi Prefecture; President & CEO: Takahiro Natsume; hereinafter “CMIC Pharma Science”) and Hamam

Announcement of an Alliance for Preclinical and Early Clinical Research and Trials in the Development of Radiopharmaceuticals in Japan

Hamamatsu Pharma Research is pleased to announce that our company, in collaboration with Hakuto Co., Ltd. and Samurai Imaging Partners Co., Ltd., has launched the “Radiopharmaceutical Drug Discovery S

HPR Presenting at the SOT, San Diego 2026

Pharmacology Research & Perspectives, vol. 13, 1.

Comments